Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

GANX holding history

Gain Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GANX overviewAll 13F holders of GANXFull Q2 2026 holdings

Shares (Q2 2026)
125,972
Value
$255.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GANX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026125,972$255.7K<0.1%−13,680−9.8%ReducedHolders
Q1 2026139,652$270.9K<0.1%−7,939−5.4%ReducedHolders
Q4 2025147,591$475.2K<0.1%−8,084−5.2%ReducedHolders
Q3 2025155,675$275.5K<0.1%+79,163+103.5%AddedHolders
Q2 202576,512$137.7K<0.1%−23,283−23.3%ReducedHolders
Q1 202599,795$190.6K<0.1%+11,283+12.7%AddedHolders
Q4 202488,512$191.2K<0.1%+83,712+1,744.0%AddedHolders
Q3 20244,800$8.54K<0.1%+1,500+45.5%AddedHolders
Q2 20243,300$4.22K<0.1%+500+17.9%AddedHolders
Q1 20242,800$10.6K<0.1%00.0%UnchangedHolders
Q4 20232,800$9.14K<0.1%+1,500+115.4%AddedHolders
Q3 20231,300$4.26K<0.1%+500+62.5%AddedHolders
Q2 2023800$3.58K<0.1%00.0%UnchangedHolders
Q1 2023800$3.86K<0.1%00.0%UnchangedHolders
Q4 2022800$2.50K<0.1%−252−24.0%ReducedHolders
Q3 20221,052$4.00K<0.1%+252+31.5%AddedHolders
Q2 2022800$3.00K<0.1%−3−0.4%ReducedHolders
Q1 2022803$3.00K<0.1%+3+0.4%AddedHolders
Q4 2021800$4.00K<0.1%00.0%UnchangedHolders
Q3 2021800$6.00K<0.1%00.0%UnchangedHolders
Q2 2021800$8.00K<0.1%00.0%UnchangedHolders
Q1 2021800$12.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.